Rare-Earth & Drug-Supply Politics: The U.S. House passed the DOMINANCE Act to reduce China’s near-total control of rare-earth processing, aiming to build allied extraction and processing hubs so defense and tech aren’t held hostage. Sanctions & Human Health: A UN rights chief warned U.S. sanctions on Cuba are driving child deaths and worsening access to medicines, with infant mortality and cancer survival rates cited as deteriorating. AI, Health Tech & Infrastructure: China is planning a massive 2 trillion yuan AI data-center buildout, while also announcing the first commercial brain-computer chip for clinical sale—raising both medical promise and safety questions. Public Health Safety Signals: A pharmacovigilance study found Candida infections are uncommon but often severe during secukinumab treatment, with most cases serious and typically appearing within 2–3 months. Food Safety Oversight: China’s regulator summoned Walmart China/Sam’s Club China over repeated food-safety violations; Walmart says it will tighten controls across the supply chain. Weight-Loss Drug Race: Novo Nordisk says it will seek approval soon for oral Wegovy in China as competition with Eli Lilly and others intensifies. Ebola Preparedness: China updated its Ebola prevention and control plan and stepped up monitoring. Drug Control Crackdown: China added 16 more non-medicinal narcotic and psychotropic substances to its control list, effective July 1. Aquaculture & Nutrition: China and South Korea released 7.29 million juveniles in the Yellow Sea to support fish stocks and marine ecosystem recovery.